In this multicentre , open-labelled , randomised non-inferiority trial , we assigned 121 patients with severe alcoholic hepatitis ( Maddrey 's discriminant function 32 ) to receive either pentoxifylline ( 400 mg , 3 times daily , in 62 subjects ) or prednisolone ( 40 mg daily , in 59 subjects ) .